查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
血管炎治疗全球市场规模调查和预测：按药物类别、疾病类型、分销渠道和地区分析，2022-2029 年
市场调查报告书
商品编码
1215482

血管炎治疗全球市场规模调查和预测：按药物类别、疾病类型、分销渠道和地区分析，2022-2029 年

Global Vasculitis Treatment Market Size study & Forecast, by Drug Class, by Disease Type, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球血管炎治疗市场价值约为 2.501 亿美元，预计在 2022-2029 年预测期内将以超过 3.4% 的健康增长率增长。

血管炎治疗是一种影响血管的罕见炎症性疾病。 这种炎症会使血管壁变厚，缩短通过它们的通道的宽度，并限制血液流动。 此外，血流受限会导致器官衰竭和组织损伤。 血管炎有多种类型，包括鉅细胞动脉炎（GCA）、大动脉炎（TAK）、主动脉炎、川崎病（KD）和结节性多动脉炎（PAN）。 血管炎的常见症状和体征包括发烧、头痛、疲劳、体重减轻和全身酸痛。 血管炎患病率上升、慢性病患病率上升以及主要参与者的战略举措是加速市场增长的关键因素。

血管炎患病率的增加促进了全球血管炎治疗市场的增长。 例如，根据 Vasculitis UK 的数据，截至 2020 年，血管炎每年影响 2000-3000 名英国居民。 此外，根据美国心臟协会杂誌——截至 2021 年 1 月，瑞典和挪威每年报告的 50 岁及以上人群中每 100,000 人中就有 20 多例 GCA 新病例。 此外，在美国，女性患 GCA 的终生风险估计为 1%，男性为 0.5%。 此外，活性药物成分 (API) 行业的快速增长和新兴市场医疗保健基础设施的改善将为预测期内的市场提供良好的增长前景。 然而，与皮质类固醇相关的副作用和不利的报销情况将阻碍整个 2022-2029 年预测期内的市场增长。

全球血管炎治疗市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于主要市场参与者的存在以及该地区血管炎发病率的增加，北美在收入方面占据了市场主导地位。 另一方面，由于老年人口增加和製药製造业扩张等因素，预计亚太地区在预测期内将以最高复合年增长率增长。

这项研究的目的是揭示近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

按药物类别

生物製品

皮质类固醇和免疫抑製剂

按疾病类型

中小血管炎

大血管炎

按销售渠道

医院药房

药店/零售商

在线药店

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 血管炎治疗市场：按地区划分，2019-2029
    • 血管炎治疗市场：按药物分类，2019-2029
    • 血管炎治疗市场：按疾病类型分类，2019-2029
    • 血管炎治疗市场：按分销渠道，2019-2029 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章血管炎治疗全球市场定义和范围

  • 调查的目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 调查年份
  • 货币兑换率

第 3 章血管炎治疗的全球市场动态

  • 血管炎治疗市场影响分析（2019-2029）
    • 市场驱动力
      • 血管炎患病率增加
      • 慢性病患病率增加
      • 主要市场参与者的战略举措
    • 市场挑战
      • 与皮质类固醇有关的副作用
      • 不利的赎回情景
    • 市场机会
      • 不断发展的活性药物成分 (API) 行业
      • 发展中地区的医疗保健基础设施有所增加

第 4 章全球血管炎治疗市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 顶级投资机会
  • 关键成功策略
  • 行业专家的展望
  • 分析师的结论和建议

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球血管炎治疗市场，按药物分类

  • 市场概况
  • 全球血管炎治疗市场，按药物类别，性能潜力分析
  • 2019-2029 年全球血管炎治疗市场、按药物类别估算和预测
  • 血管炎治疗市场细分分析
    • 生物製剂
    • 皮质类固醇
    • 免疫抑製剂

第 7 章：全球血管炎治疗市场，按疾病类型分类

  • 市场概况
  • 全球血管炎治疗市场：按疾病类型进行性能潜力分析
  • 全球血管炎治疗市场、按疾病类型估计和预测 (2019-2029)
  • 血管炎治疗市场细分分析
    • 中小型血管炎
    • 大血管炎

第 8 章全球血管炎治疗市场：按分销渠道

  • 市场概况
  • 全球血管炎治疗市场：按分销渠道进行的性能潜力分析
  • 全球血管炎治疗市场、按分销渠道估算和预测 (2019-2029)
  • 血管炎治疗市场细分分析
    • 医院药房
    • 药店、零售药店
    • 在线药店

第 9 章全球血管炎治疗市场：区域分析

  • 血管炎治疗市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年按药物类别的估计和预测
      • 按疾病类型估算和预测，2019-2029 年
      • 按销售渠道估算和预测，2019 年至 2029 年
    • 加拿大
  • 欧洲血管炎治疗市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区血管炎治疗市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲血管炎治疗市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地区

第 10 章衝突信息

  • 顶级市场策略
  • 公司简介
    • Amneal Pharmaceuticals Inc.
      • 主要信息
      • 概览
      • 财务信息（取决于数据可用性）
      • 产品概述
      • 近期趋势
    • AstraZeneca plc
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • InflaRx N.V
    • Novartis AG
    • ChemoCentryx Inc.
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.

第 11 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查属性
  • 调查先决条件

Global Vasculitis Treatment Market is valued at approximately USD 250.1 million in 2021 and is anticipated to grow with a healthy growth rate of more than 3.4% over the forecast period 2022-2029. Vasculitis Treatment is a rare inflammatory disease which affects blood vessels. The inflammation causes the walls of the blood vessels to thicken, which shortens the width of the passageway through the vessel and restricts blood flow. Moreover, restricted blood flow can result in organ failure and tissue damage. There are many types of vasculitis, such as Giant cell arteritis (GCA), Takayasu's arteritis (TAK), Aortitis, Kawasaki disease (KD), and Polyarteritis nodosa (PAN) among others. The general symptoms and signs of Vasculitis include Fever, Headache, Fatigue, Weight loss, General aches, pains, etc. The increasing vasculitis prevalence and growing incidences of chronic diseases as well as strategic initiatives from leading market players are key factors accelerating the market growth.

The increasing incidences of vasculitis prevalence are contributing towards the growth of the Global Vasculitis Treatment Market. For instance - according to Vasculitis UK - as of 2020, vasculitis affects 2000 to 3000 UK residents every year. Moreover, as per American Heart Association Journal - as of January 2021, in Sweden and Norway more than 20 new cases of GCA per 100 000 individuals aged 50 years and older are reported every year. Additionally, the lifetime risk of developing GCA is estimated at 1% for women and 0.5% for men in the United States. Also, the rapid growth of active pharmaceutical ingredient (API) industry and rising healthcare infrastructure in developing regions would create a lucrative growth prospectus for the market over the forecast period. However, side effects associated with corticosteroids and unfavorable reimbursement scenarios stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Vasculitis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of leading market players and increasing incidences of vasculitis in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric populations, and increasing expansion of pharmaceuticals manufacturing sector in the region.

Major market players included in this report are:

Amneal Pharmaceuticals Inc.

AstraZeneca plc

F. Hoffmann-La Roche Ltd

GlaxoSmithKline plc

Pfizer Inc.

InflaRx N.V

Novartis AG

ChemoCentryx Inc.

AbbVie Inc.

Teva Pharmaceutical Industries Ltd.

Recent Developments in the Market:

  • In September 2021, Vifor Fresenius Medical Care Renal Pharma (VFMCRP) announced that Japan's Ministry of Health and Labor Welfare (MHLW) has granted its partner, Kissei Pharmaceutical Co., Ltd., approval for marketing of TAVNEOS® for the treatment of patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).
  • In October 2022, Amgen completed its planned acquisition of ChemoCentryx, Inc. for a transaction value of USD 3.7 billion. This acquisition also includes TAVNEOS, an orally administered inhibitor that was approved by the U.S. Food and Drug Administration (FDA) in October 2021 for the treatment of severe active ANCA-associated vasculitis.

Global Vasculitis Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug Class, Disease Type, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class

Biologics

Corticosteroids and immunosuppressants

By Disease Type

Small and medium vessel vasculitis

Large vessel vasculitis

By Distribution Channel

Hospital pharmacies

Drug stores and retail pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Vasculitis Treatment Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Vasculitis Treatment Market, by Drug Class, 2019-2029 (USD Million)
    • 1.2.3. Vasculitis Treatment Market, by Disease Type, 2019-2029 (USD Million)
    • 1.2.4. Vasculitis Treatment Market, by Distribution Channel, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Vasculitis Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Vasculitis Treatment Market Dynamics

  • 3.1. Vasculitis Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing vasculitis prevalence
      • 3.1.1.2. Growing incidences of chronic diseases
      • 3.1.1.3. Strategic initiatives from leading market players
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects associated with corticosteroids
      • 3.1.2.2. Unfavourable reimbursement scenario
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing active pharmaceutical ingredient (API) industry
      • 3.1.3.2. Rising healthcare infrastructure in developing regions

Chapter 4. Global Vasculitis Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Vasculitis Treatment Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Vasculitis Treatment Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Vasculitis Treatment Market Estimates & Forecasts by Drug Class 2019-2029 (USD Million)
  • 6.4. Vasculitis Treatment Market, Sub Segment Analysis
    • 6.4.1. Biologics
    • 6.4.2. Corticosteroid
    • 6.4.3. Immunosuppressants

Chapter 7. Global Vasculitis Treatment Market, by Disease Type

  • 7.1. Market Snapshot
  • 7.2. Global Vasculitis Treatment Market by Disease Type, Performance - Potential Analysis
  • 7.3. Global Vasculitis Treatment Market Estimates & Forecasts by Disease Type 2019-2029 (USD Million)
  • 7.4. Vasculitis Treatment Market, Sub Segment Analysis
    • 7.4.1. Small and medium vessel vasculitis
    • 7.4.2. Large vessel vasculitis

Chapter 8. Global Vasculitis Treatment Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Vasculitis Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Vasculitis Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
  • 8.4. Vasculitis Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital pharmacies
    • 8.4.2. Drug store and retail pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Vasculitis Treatment Market, Regional Analysis

  • 9.1. Vasculitis Treatment Market, Regional Market Snapshot
  • 9.2. North America Vasculitis Treatment Market
    • 9.2.1. U.S. Vasculitis Treatment Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Disease Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Vasculitis Treatment Market
  • 9.3. Europe Vasculitis Treatment Market Snapshot
    • 9.3.1. U.K. Vasculitis Treatment Market
    • 9.3.2. Germany Vasculitis Treatment Market
    • 9.3.3. France Vasculitis Treatment Market
    • 9.3.4. Spain Vasculitis Treatment Market
    • 9.3.5. Italy Vasculitis Treatment Market
    • 9.3.6. Rest of Europe Vasculitis Treatment Market
  • 9.4. Asia-Pacific Vasculitis Treatment Market Snapshot
    • 9.4.1. China Vasculitis Treatment Market
    • 9.4.2. India Vasculitis Treatment Market
    • 9.4.3. Japan Vasculitis Treatment Market
    • 9.4.4. Australia Vasculitis Treatment Market
    • 9.4.5. South Korea Vasculitis Treatment Market
    • 9.4.6. Rest of Asia Pacific Vasculitis Treatment Market
  • 9.5. Latin America Vasculitis Treatment Market Snapshot
    • 9.5.1. Brazil Vasculitis Treatment Market
    • 9.5.2. Mexico Vasculitis Treatment Market
    • 9.5.3. Rest of Latin America Vasculitis Treatment Market
  • 9.6. Rest of The World Vasculitis Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Amneal Pharmaceuticals Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. AstraZeneca plc
    • 10.2.3. F. Hoffmann-La Roche Ltd
    • 10.2.4. GlaxoSmithKline plc
    • 10.2.5. Pfizer Inc.
    • 10.2.6. InflaRx N.V
    • 10.2.7. Novartis AG
    • 10.2.8. ChemoCentryx Inc.
    • 10.2.9. AbbVie Inc.
    • 10.2.10. Teva Pharmaceutical Industries Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Vasculitis Treatment Market, report scope
  • TABLE 2. Global Vasculitis Treatment Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Vasculitis Treatment Market estimates & forecasts by Drug Class 2019-2029 (USD Million)
  • TABLE 4. Global Vasculitis Treatment Market estimates & forecasts by Disease Type 2019-2029 (USD Million)
  • TABLE 5. Global Vasculitis Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
  • TABLE 6. Global Vasculitis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Vasculitis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Vasculitis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Vasculitis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Vasculitis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Vasculitis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Vasculitis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Vasculitis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Vasculitis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Vasculitis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. U.S. Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 20. Canada Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. Canada Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 23. UK Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. UK Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 26. Germany Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. Germany Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 29. France Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. France Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 32. Italy Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Italy Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 35. Spain Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. Spain Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 38. RoE Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. RoE Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 41. China Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. China Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 44. India Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. India Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 47. Japan Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. Japan Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 50. South Korea Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. South Korea Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 53. Australia Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. Australia Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 59. Brazil Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Brazil Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 62. Mexico Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. Mexico Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 65. RoLA Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. RoLA Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 68. Row Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. Row Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Vasculitis Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Vasculitis Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Vasculitis Treatment Market, research methodology
  • FIG 2. Global Vasculitis Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Vasculitis Treatment Market, key trends 2021
  • FIG 5. Global Vasculitis Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Vasculitis Treatment Market, porters 5 force model
  • FIG 7. Global Vasculitis Treatment Market, pest analysis
  • FIG 8. Global Vasculitis Treatment Market, value chain analysis
  • FIG 9. Global Vasculitis Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Vasculitis Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Vasculitis Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Vasculitis Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Vasculitis Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Vasculitis Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Vasculitis Treatment Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Vasculitis Treatment Market 2019 & 2029 (USD Million)
  • FIG 17. Asia Pacific Vasculitis Treatment Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Vasculitis Treatment Market 2019 & 2029 (USD Million)
  • FIG 19. Global Vasculitis Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable